CLPT logo

ClearPoint Neuro, Inc. Stock Price

NasdaqCM:CLPT Community·US$755.9m Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 14 Fair Values set on narratives written by author

CLPT Share Price Performance

US$26.39
14.77 (127.11%)
9.0% undervalued intrinsic discount
US$29.00
Fair Value
US$26.39
14.77 (127.11%)
9.0% undervalued intrinsic discount
US$29.00
Fair Value
Price US$26.39
AnalystConsensusTarget US$29.00

CLPT Community Narratives

AnalystConsensusTarget·
Fair Value US$29 9.0% undervalued intrinsic discount

Minimally Invasive Neurosurgery Will Improve Global Clinical Outcomes

0users have liked this narrative
0users have commented on this narrative
9users have followed this narrative

Recent CLPT News & Updates

ClearPoint Neuro: AMT-130 Highlights A Bright Future

Oct 02

Why Investors Shouldn't Be Surprised By ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) 84% Share Price Surge

Sep 25
Why Investors Shouldn't Be Surprised By ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) 84% Share Price Surge

After Leaping 31% ClearPoint Neuro, Inc. (NASDAQ:CLPT) Shares Are Not Flying Under The Radar

May 04
After Leaping 31% ClearPoint Neuro, Inc. (NASDAQ:CLPT) Shares Are Not Flying Under The Radar

ClearPoint Neuro: Fundamentals Continue To Strengthen

Apr 29

ClearPoint Neuro, Inc. Key Details

US$33.6m

Revenue

US$13.3m

Cost of Revenue

US$20.3m

Gross Profit

US$42.5m

Other Expenses

-US$22.2m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
-0.78
Gross Margin
60.42%
Net Profit Margin
-66.15%
Debt/Equity Ratio
146.1%

ClearPoint Neuro, Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Flawless balance sheet with limited growth.

2 Risks
1 Reward

About CLPT

Founded
1998
Employees
115
CEO
Joseph Burnett
WebsiteView website
www.clearpointneuro.com

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V.; UCB Biopharma SRL; NE Scientific, LLC; and University of California, San Francisco, and Johns Hopkins University. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

U.S. Market Performance

  • 7 Days: 0.4%
  • 3 Months: 7.8%
  • 1 Year: 17.8%
  • Year to Date: 14.7%
In the last week, the market has stayed flat, however the Healthcare sector stood out, gaining 3.7%. As for the longer term, the market has risen 18% in the past 12 months. Looking forward, earnings are forecast to grow by 15% annually. Market details ›